Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
about
Role of glycosphingolipids in the function of human serotonin₁A receptorsCholesterol, lipid rafts, and diseaseVirus entry, assembly, budding, and membrane raftsNonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infectionLipids and membrane microdomains in HIV-1 replicationGlycosphingolipid-Protein Interaction in Signal TransductionMosquito cellular factors and functions in mediating the infectious entry of chikungunya virusDeciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptideRole of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cellsGlobotriaosyl ceramide receptor function - where membrane structure and pathology intersect.Presentation of membrane-anchored glycosphingolipids determined from molecular dynamics simulations and NMR paramagnetic relaxation rate enhancement.New cholesterol-specific antibodies remodel HIV-1 target cells' surface and inhibit their in vitro virus production.PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infectionSegregation of leading-edge and uropod components into specific lipid rafts during T cell polarizationModulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.The Role of Lipids in Retrovirus Replication.Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.Role of sphingolipids in microbial pathogenesisAsymmetric requirement for cholesterol in receptor-bearing but not envelope-bearing membranes for fusion mediated by ecotropic murine leukemia virusRole for human immunodeficiency virus type 1 membrane cholesterol in viral internalization.Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion.Modulation of hepatitis C virus genome replication by glycosphingolipids and four-phosphate adaptor protein 2.Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.Chemokine receptor internalization and intracellular trafficking.Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusionLipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains.Lipidomics of host-pathogen interactions.CXCR4-tropic, but not CCR5-tropic, human immunodeficiency virus infection is inhibited by the lipid raft-associated factors, acyclic retinoid analogs, and cholera toxin B subunit.Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.Sphingomyelin modulates the transbilayer distribution of galactosylceramide in phospholipid membranesGlycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection.Atomic-resolution conformational analysis of the GM3 ganglioside in a lipid bilayer and its implications for ganglioside-protein recognition at membrane surfaces.Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.Dendrimers as potential therapeutic tools in HIV inhibition.CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4.
P2860
Q24298268-B493CD45-6B78-4ED5-BC0F-46991C2046F1Q24553188-F6BA76F1-D714-4006-B5A5-1156968E914EQ24673161-F3B82927-2262-4FF8-AFC1-228A9CD17808Q27473003-CD8A5312-084B-4B34-84ED-43E65D73881AQ27489393-FD0071BD-E588-4E55-B1D9-A3F292A98872Q28072827-84D1C1E6-F50A-4937-B54B-09930757B552Q28486029-6E0E37F9-4A40-406B-98DC-876AEB4D0070Q28542419-4BB970CD-F278-4A1E-BCE3-F6BA4CD27DAEQ30865013-C6D14CC2-1B34-4CC8-8D84-73289B768982Q33387236-F9E6C9E1-B919-415B-82CB-587067A9B54CQ33522683-38C95E85-E13C-4393-8947-2BD0C53FD154Q33577826-0DD4C37D-C83E-40EA-8CA9-338EA0761325Q33628817-A8741756-3444-473F-AF74-2D2AF9F0C8FFQ33933192-9CD3ED1C-4F71-4B5B-B5C0-A3A2A9BCBDD2Q33967491-C6580D9A-85D6-4490-BC0A-E0386546B1FEQ33984243-A40542BD-FA62-4D5C-A42C-C5BB20EE6EE2Q34001144-1B85F58A-A9FF-4610-BDE0-E191A1410E10Q34080779-B207755B-2577-4F13-BC03-E7237B9CDA75Q34124118-84ED226D-377D-4712-A85F-4A50A48343A5Q34253227-40384041-918F-4A15-89FE-3D231D7BD1D8Q34300991-3A6661E1-4F4A-4E1C-8F11-17B165D1B7C5Q34341238-783FF3C8-C209-46EE-9BB5-C7554B664913Q34348930-8E0660D9-B92D-4987-B0ED-54B50D675FA6Q34431138-C8055C29-50C2-4FC8-ACE6-A9A1DCAD2A87Q34593688-8133FC94-11EE-46DF-9EA4-D2F7E1DE6852Q35122813-77A01500-9452-4FD6-996D-E4C79D5AB6D7Q35585420-24F32FE5-47C8-43F8-95BF-511BDF80E648Q36184275-EF24E479-FD99-46F3-8CB2-E2EE0A5BEB98Q36303032-BE577EDF-B2D3-4AC7-A4C6-0A0FBC9E13C5Q36370336-62953894-FC7F-4801-9855-55E9AEE02DAEQ36370878-F9B72365-A6C0-4973-A9D3-03CB7D2AC570Q36543297-B1F0084D-2658-41E7-A9A2-8897E2F77292Q36553987-EEED6343-D206-45D3-8887-09EB23080441Q36940332-47C175BA-9F50-4A06-9FC7-03DC1C944FF2Q37034681-0A4DC0BF-121B-4159-B8EC-77127681ECA6Q37145333-AFF1E716-53F2-4B25-8810-8E4EF5AB7B81Q37323223-06FCBF28-A59C-41D5-B70C-BE1AAB1A61DDQ37734096-A382CCA5-A301-4AF4-8B4B-D23BC51468ECQ38123954-7BD71F37-0655-41C7-AF5D-B0C9426048E0Q38348905-0B4545BE-9127-4169-8FE3-F25C7AF30935
P2860
Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Glycosphingolipids promote ent ...... ssing CD4, CXCR4, and/or CCR5.
@ast
Glycosphingolipids promote ent ...... ssing CD4, CXCR4, and/or CCR5.
@en
type
label
Glycosphingolipids promote ent ...... ssing CD4, CXCR4, and/or CCR5.
@ast
Glycosphingolipids promote ent ...... ssing CD4, CXCR4, and/or CCR5.
@en
prefLabel
Glycosphingolipids promote ent ...... ssing CD4, CXCR4, and/or CCR5.
@ast
Glycosphingolipids promote ent ...... ssing CD4, CXCR4, and/or CCR5.
@en
P2093
P2860
P1433
P1476
Glycosphingolipids promote ent ...... ssing CD4, CXCR4, and/or CCR5.
@en
P2093
D S Dimitrov
R Blumenthal
P2860
P304
P356
10.1128/JVI.74.14.6377-6385.2000
P577
2000-07-01T00:00:00Z